National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals and home infusion facilities - 1995

American Journal of Health-System Pharmacy

Volumn 53, Issue 21, 1996, Pages 2591-2605

  Santell, John P ^a,c   Kamalich, Richard F ^b  

^a ASHP   (United States)

^b Amer Soc Hlth Syst Pharmacists ^*

^c AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS   (United States)

Author keywords

Additives; Administration; Automation; Compounding; Contamination; Contract services; Control, quality; Data collection; Education, pharmaceutical; Expiration dates; Filtration; Health care; Injections; Personnel, pharmacy; Pharmacists; Pharmacists, hospital; Pharmacy, institutional, hospital; Planning and design; Quality assurance; Sterile products; Sterility; Sterilization; United States

Indexed keywords

ARTICLE; AUTOMATION; CONTAMINATION; DATA ANALYSIS; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HOSPITAL CARE; INFUSION; INSTRUMENT STERILIZATION; PHARMACY; PLANNING; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 0029951761     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.21.2591     Document Type: Article

References (15)

1. Crawford SY, Narducci WA, Augustine SC. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals. Am J Hosp Pharm. 1991; 48:2398-413.
2. American Society of Hospital Pharmacists. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. Am J Hosp Pharm. 1993; 50:2386-98.
3. Santell JP. ASHP national survey of hospital-based pharmaceutical services - 1994. Am J Health-Syst Pharm. 1995; 52:1179-98.
4. Hughes CF, Grant AF, Leckie BD et al. Cardioplegic solutions: a contamination crisis. J Thorac Cardiovasc Surg. 1986; 91:296-302.
5. Solomon SL, Khabbaz RF, Parker RH et al. An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis. 1984; 149:98-102.
6. Medication is tainted; 4 die in same hospital. N Y Times. 1990; Jun 26:A16.
7. ASHP gears up multistep action plan regarding sterile drug products. Am J Hosp Pharm. 1991; 48:386-90. News.
8. Food and Drug Administration. Title 21 Code of Federal Regulations. Part 21 - current good manufacturing practice for finished pharmaceuticals, United States.
9. The United States pharmacopeia, 23rd rev., and The national formulary, 18th ed. Rockville, MD: The United States Pharmacopeial Convention; 1995.
10. Chandler SW, Trissel LA, Wamsley LM et al. Evaluation of air quality in a sterile-drug preparation area with an electric particle counter. Am J Hosp Pharm. 1993; 50:2330-4.
11. Choy FN, Lamy PP, Burkhart VD et al. Sterility-testing program for antibiotics and other intravenous admixtures. Am J Hosp Pharm. 1982; 39:452-6.
12. Doss HL, James JD, Killough DM et al. Microbiologic quality assurance for intravenous admixtures in a small hospital. Am J Hosp Pharm. 1982; 39:832-5.
13. Sterile drug products for home use. Rockville, MD: The United States Pharmacopeial Convention; 1995.
14. National Coordinating Committee on Large Volume Parenterals. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. Am J Hosp Pharm. 1975; 32:261-70.
15. McKinnon BT, Avis KE. Membrane filtration of pharmaceutical solutions. Am J Hosp Pharm. 1993; 50:1921-36.